Site Search

… cellular breakdowns highlight joint conference of MIT’s Aging Brain Initiative and Alana Down Syndrome Center … research and discuss the many intersections they see among Alzheimer’s and other dementias, Parkinson’s disease, … potential therapy for a subset of cases of frontotemporal dementia. In those cases, mutations reduce levels of …

… produces cognitive benefits. 40Hz Down syndrome Alzheimer's dementia gamma Alana Down Syndrome Center team recruiting …

… to create a nanosensor-integrated brain-on-a-chip model of Alzheimer’s disease. stem cells organoids Alzheimer's dementia neurodegeneration ‘Career Award at the Scientific …

… and why you might consider it, too. Prevention of Alzheimer's Disease in those at High Risk No history of seizure or … or past history of any neurological disorder other than dementia The investigators are recruiting 60 participants who …

… surveys a broadening landscape of studies showing what’s known, and what remains to be found, about the therapeutic … of gamma brain rhythms. neurodegeneration gamma dementia 40Hz … produce meaningful therapeutic effects for people with Alzheimer’s disease. In a new review paper in the Journal of …

… for inflammation in the brain, a prominent symptom in Alzheimer’s disease neuroimmunology Neuroimmune interactions microglia neurodegeneration dementia …

… afforded by the Dana and Betty Fisher retreat astrocytes Alzheimer's dementia Every year members of The Picower Institute find …

… States https://whereis.mit.edu/?go=46 Aging Brain Seminars Alzheimer's Disease Public Event Aging Brain Seminar with Mark Gluck, … disease. We focus on populations with elevated risk for dementia, especially African Americans, who suffer from …

… States https://whereis.mit.edu/?go=46 Aging Brain Seminars Alzheimer's Disease Public Event The Knotty Problem of Neurofibrillary … diseases range from Alzheimer’s disease to frontotemporal dementia to chronic traumatic encephalopathy. Their shared …

… functions. This enzyme is often diminished in both Alzheimer’s patients and normally aging adults. In a study of mice, the … Exifone was approved in the 1980s in Europe to treat dementia but was later taken off the market because it caused …